No abstract available
Keywords:
chronic myeloid leukaemia; imatinib; molecular fluctuation; prognosis; resistance.
MeSH terms
-
Female
-
Fusion Proteins, bcr-abl* / genetics
-
Fusion Proteins, bcr-abl* / metabolism
-
Humans
-
Imatinib Mesylate / administration & dosage*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / enzymology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / genetics
-
Male
-
Middle Aged
Substances
-
BCR-ABL1 fusion protein, human
-
Imatinib Mesylate
-
Fusion Proteins, bcr-abl